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SUMMARY 
• Siibmandibular rat 1 protein (SMR1) preprohormo- 
ne and its maturation peptides constitute the novel cha 
racterized submandibular gland (SMG)-specific factors of the 
cervical sympathetic trunk (CST)-SMG (CST-SMG) axis. As is 
generally observed for major polypeptide hormones of the 
endocrine system, SMR1 peptides, including SMR1- 
imdecapeptide, -hexapeptide and -pentapeptide, are selec 
tively matured from the precursor by cleavage at pairs of basic 
residues, and differentially accumulated and locally as well as 
systemically released under multifactorial n euro endocrine 
control. In turn, the final SMRl mature pentapeptide, at 
hormonal circulating concentrations, is selectively taken up 
by peripheral targets through specific binding sites. Localiza 
tion of the target cells suggests that the SMRl-derived pen 
tapeptide might be involved in modulating mineral ion bal 
ance in vivo. Furthermore, associated with male rat specific 
behavioral characteristics, one can propose that the andro- 
gen-regulated SMRl-pentapeptide is a SMG hormonal factor, 
which under stressful circumstances, is acutely secreted to 
counterregulate the mineral homeostatic responses to stress. 
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The gene VCSA1, which encodes SMRl, belongs to a new mu-
Itigene family, essentially expressed in the salivary glands of 
mammals. This family, whose several members also display 
putative sites of processing by convertases, has an unusual 
evolution characterized by multiple gene duplications and an 
accelerated divergence of coding sequences. (Biomed Rev 
1998; 9: 17-32) 
INTRODUCTION 
• When studying submandibular glands (SMG) and 
their products, two observations are particularly puzzling: (i) 
these glands secrete in large quantities hormones, growth fac 
tors and enzymes mostly known for their systemic functions 
(1,2), and (ii) important species differences and frequent sexual 
dimorphism, especially in rodents, are observed at the histologi- 
cal and biochemical levels. In particular, the proteins synthe 
sized by the SMG are quite different both quantitatively and qu 
alitatively from one species to another. The diversification of the 
salivary proteins according to species and the existence of 
sexual dimorphism, led us and others, to propose that some sali 
vary polypeptides might be involved in the establishment of 
species specific characteristics in relation with male mecha 
nisms by which the corresponding genes have been recruited 
to fulfill these specific functions include changes in the regula 
tion of gene expression, and/or appearance of salivary gene 
variants with modified functions by gene duplication followed 
by sequence divergence. For instance, renin is an enzyme pro 
duced by the juxtaglomerular cells of the kidney which is 
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involved in the regulation of blood pressure and hydromineral 
homeostasis. In the male mouse, an important extrarenal source for 
renin synthesis is the SMG (3). Renin of salivaty origin is not 
glycosylated and differs from renal renin by its lower stability 
(4). Salivary renin is secreted both into the saliva and the blood, 
particularly during the aggressive behaviors of male mice (5). 
However, no effect of this secretion on peripheral blood 
pressure has yet been demonstrated. From the genetic point 
of view, renin synthesis in the SMG is linked to a gene duplication. 
This gene duplication is only found in the mouse which is the 
only species known to synthesize renin in the SMG (6-9). In the 
rat SMG, a number of genes are expressed at a higher level in 
males than in females, e.g. the genes encoding kallikreins, 
epidermal growth factor (EOF), transforming growth factor-beta 
(TGF-p),andsubmandibularrat 1 and2proteins(SMRl,SMR2), 
respectively. 
CHARACTERIZATION OF THE GENE 
ENCODING A NEW POLYPEPTIDE 
HORMONE PRECURSOR NAMED SMR1 
• Structure of the VCSA1 gene encoding SMR1 
When the in vitro translation products from RNA obtained from 
SMG of male and female rats are compared, some polypeptides 
appear differentially expressed according to the sex (10). SMR1 
was firstly described as one of these polypeptides whose 
expression is higher in males than in females. Using a differential 
screening strategy, we cloned the corresponding cDNA from a 
SMG cDNA library (10). Analysis of the SMR1 cDNA sequence 
led us to postulate that SMR1 might be a new preprohonnone: 
the sequence of SMR1 contains signals for secretion and 
processing by convertases. The sequence and structure of 
the gene encoding SMR1, also called the VCSA1 gene, have 
been elucidated(l 1,12).The VCSA1 gene is on rat chromosome 
14/ p21 -22 (13). Different mRNAs, generated by differential 
maturation of the primary transcripts, have been characterized in 
the rat SMG (12). Four of them only differ by the length of their 
untranslated regions (3' UTR) and all encode SMR1. The 
most abundant and first described transcript is about 700 b 
long. It contains 438 nucleotides (nt) ORF encoding the SMR1 
poly-peptide, together with 86 and 142 nt 5' and 3' UTR, 
respectively. Sequence comparison between cDNA and genomic 
DNA reveals the presence of two introns. In the mature mRNA, 
exon 1 corresponds to most of the 5'UTR, exon 2 encodes most 
of the signal peptide, and the third exon which is unusually long 
(more than 500 nt) encodes the last 4 amino acids of the 
signal peptide, the whole mature protein and the 3'UTR. 
Interestingly, the structure of the VCSA1 gene is reminiscent of 
the structure of several genes encoding prohormones, such as the 
genes for preprothyrotropin-releasing hormone, 
preproenkephalins or preproopiomelanocortin (11). Whether 
this structure reflects the existence of a common ancestor, or 
convergent evolution, is at present not known. 
• The VCSA1 gene encoding SMR1 is a member of a 
new multigene family, the VCS family 
Probing genomic DNA blots with SMR1 cDNA showed that a 
number of related sequences are found in rat genome (10,14). 
Subsequent cloning and characterization of a number of genes 
related to SMR1 gene in the rat, but also in the mouse and in the 
human, confirmed that it belongs to a multigene family. Sequencing 
of some of these related genes revealed the presence of a 
"hypervariable sequence" covering a large part of the coding 
sequence (about 150-200 nt), where sequence similarity sharply 
drops. For this reason, this family has been named variable 
coding sequence (VCS) family, and the SMR1 gene was also 
called VCSA1 gene. As a result of this variation, the protein 
sequences also differ notably in this region (Fig. 1). Although 
located outside the hypervariable sequence, the C-terminus of 
the proteins is also variable in length, which introduces an 
additional level of variability between VCS gene products. 
Whereas the VCS genes encode proteins which are very different 
in sequence and therefore probably in function, they 
nevertheless share a number of properties which enable one to 
group them into a family. Indeed, the different genes characterized 
to date, generally present (i) a common structure resembling that 
of VCS A1, (ii) sequence similarities which are mainly observed 
in the first and second exons, as well as in the beginning 
and the 3' end of the third exon, and (Hi) at the amino acid level, a 
relatively good conservation of the 35 first amino acids of the 
VCS gene products, with the first 20 amino acids corresponding 
to the signal peptide, i.e. the VCS gene products are most likely 
secreted. The RXYR sequence, generally RGPR, which is a good 
recognition site for convertases (15,16), is also conserved in the 
N-terminus of VCS gene encoded proteins. Therefore, most of 
the VCS gene products might be proteolyti-cally processed at this 
site. A common chromosomal localization in the rat all the VCS 
genes characterized so far have been mapped in chromosome 
14/p21 -22 (13). Due to conservation of syntenic groups between 
rat, mouse and human, the VCS genes are expected to map on 
mouse chromosome 5 and human chromosome 4. Indeed this 
localization has been confirmed for one of the mouse VCS 
genes (Senorale et al, submitted for publication) and one of the 
human VCS genes. The main characteristics of some of the 
known VCS genes are summarized in Table 1. 
The VCSA genes, VCSA1 (SMR1 gene), VCSA2 and VCSA3, 
form a subgroup of closely related genes in the rat and encode 
SMR1 and SMR1-related polypeptides (17). These 
polypeptides, which contain potential recognition sites for 
proteolytic enzymes, can all be considered as potential 
preprohormones whose expression is spatiotemporally regulated. 
While VCSA 1 is mostly expressed in the SMG of sexually 
mature male rats, VCS A2 is expressed in young (0-18 days after 
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Figure 1. Sequence comparison of VCS gene proteins. * amino acid conservation in all sequences; +, a conservation in at 
least 6 among the 9 sequences. 
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(Rosinski-Chupin and Courty , unpublished data), and no site of 
expression for VCSA3 has been characterized to date. 
Sequence analysis of these genes reveals that they evolved after 
recent duplications of an ancestor (17). 
VCS2 is the mouse gene most related to the VCSA subgroup 
(18,19). It is expressed in mouse SMG in response to androgens, 
like VCSA 1, but at a lower level. Its structure is relatively unusual 
for a member of the VCS family since it is composed of 6 exons, due 
to the juxtaposition of three VCS sequences following events 
of gene fusion. Five mRNAs resulting from alternative splicing 
of the same primary messenger were characterized. Three of 
the encoded proteins have a structure similar to SMR1 and might 
be processed to release low molecular weight pep-tides. 
The rat VCSB1, the mouse VCS 1, the human H-PB and H-PBI 
genes encode polypeptides containing repetitions of a proli-
nerich sequence, GPGXXPPPP (14,19-22). These polypeptides 
also contain potential sites for maturation enzymes. The mouse 
and rat genes are expressed in the acinar cells of parotids, while 
H-PB is expressed in the human SMG. The presence of potential 
sites for bacterial collagenases lead to proposition that these 
proteins might have a role in buccal protection by inhibiting 
collagenases. In addition, arole in tooth mineralization has been 
also proposed after the discovery of a P-B-like peptide as a tooth 
enamelin (23). Based on nucleotide similarities in the 5'UTR 
region and the beginning of the coding sequence, a fifth gene, 
 
 
encoding a lacrimal proline-rich protein in humans also seems 
to belong to this group of VCS genes (24). 
• Evolutionary events leading to VCSA1 gene expres 
sion in rat submandibular glands 
VCSA1 (SMR1) gene belongs to a family whose major site of 
expression is the salivary glands. Sequence comparisons with 
related genes in the same or different species reveal that VCSA 1 is 
a relatively new gene, specific for the Rattus genus, whose 
sequence has diverged from other VCS sequences after gene 
duplication. In fact, VCSA1 coding sequence can be split into 
several regions apparently evolving at different rates. The 
hypervariable region is hardly conserved in other VCS genes 
and would appear to have evolved at an accelerated rate. 
Studying the VCSA subgroup of genes in the Rattus genus, lead 
to the conclusion that sequence divergence in this region is due 
to the presence of multiple insertions, deletions or mutations. 
Interestingly, most of these mutations are not silent and lead to 
amino acid substitutions, suggesting that evolution of this 
region might be driven by mechanisms promoting sequence 
diversification (17). Contrasting with the hypervariable region, 
the first N-terminal amino acids which include the signal peptide 
and the first potential proteolytic site are well conserved 
between the human, mouse and rat genes. The adjacent sequence 
which corresponds to the polypeptide hormone is found more or 
less conserved and is followed by a second putative 
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proteins. Whether this sequence has been recently gained 
during evolution, or has been lost in human proline-rich 
proteins, is not known and a more extensive characterization of 
VCS genes in other species is necessary to answer this 
question. 
In conclusion, this dual evolution might signify that at least two 
different functions are carried by the VCS gene encoded 
proteins: one function, linked to the capacity to generate low 
molecular weight peptides, is relatively common to the family, 
and the other function carried by the hypervariable peptidic 
region would be more polypeptide-specific. 
MATURATION PEPTIDES OF SMR1 PRECURSOR 
• SMR1 maturation polypeptides 
Hormonal precursors of the endocrine system generate biological 
active peptides by selective proteolytic cleavages at paired and 
single basic amino acids (26,27). The SMR1 protein struc- 
ture displays features common to these polypeptide hormone 
precursors: it contains an N-terminal secretory signal sequence of 
hydrophobic amino acids and sites for a limited and controlled 
endoproteolytic process. On the one hand, two potential sites of 
paired arginine residues are present in the N-terminus of the 
sequence R27-R28 and R33-R34 (Fig. 2) and have the 
environmental characteristics required to direct cleavage by 
the paired basic amino acid maturases, such as furin which is 
widely distributed within the rodent SMG (28). Thus, the two 
dibasic sites encompass, in a hydrophilic region, a tetrapeptide 
(QHNP) and basic amino acid occupies the P4 position relative 
to each cleavage site (R/H-X-Y-R-R). On the other hand, a single 
basic amino acid is present in the median part of the SMR1 
sequence R 70 (Fig. 2). Single and pairs of basic amino acids are 
essential processing sites for the generation of biologically 
active pep-tides. However, their selection is limited and 
dictated by the nature and activity of converting enzyme as 
well as by the primary, secondary and tertiary structure of the 
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Figure 2. Schematic diagram ofSMRI preprotein structure and of its derived peptides which are maturated from precursor 
by selective cleavages at dibasic Arg-Arg sites. The processing mono- and dibasic sites are denoted by arrows. The single and 
pairs of basic residues are given by single-letter amino-acid symbols. Three structurally related peptides have been 
characterized from the SMG of adult male rats. All are generated from SMR1 precursor by selective cleavages at both Arg-Arg 
bonds. 
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In vivo, SMR1 protein is selectively processed at pairs of basic 
amino acid sites in a tissue- and sex- specific manner to give rise to 
mature peptide products, in a manner similar to the maturation 
pathway of polypeptide hormone precursors (31). Three 
structurally related peptides have been isolated and 
characterized from the SMG and prostate of adult male rats. 
Theundecapepti-de VRGPRRQHNPR is generated from SMR1 
by selective en-doproteolysis at the Arg33-Arg34 bond and 
at the signal peptide cleavage site. The hexapeptide RQHNPR 
and the pen-tapeptide QHNPR are generated by selective 
cleavages at both Arg27-Arg28 and Arg37-Arg38 bonds 
occurring either between or following pairs of basic residues. 
The final processed peptide named SMR1 -pentapeptide appears 
in two forms, one with the N-terminal glutamine and other with the 
N-terminal py-roglutamate (Fig.2) (31). Furthermore, as revealed by 
in vitro metabolic experiments employing radiolabeled peptide 
added to various biological fluids and tissue extracts, the SMR1 -
undeca-peptide is the direct precursor of the SMR1-hexapeptide 
and SMR 1 -pentapeptide in the rat SMG and its secretions into 
saliva and bloodstream. Differently, peptides with various 
degrees of glycosylation corresponding to the C-terminus of 
SMR1 protein have been isolated and characterized from the saliva 
of male rat. They are generated by limited cleavage at the 
monobasic Arg70 site (in collaboration withNG Seidah, IRCM, 
Montreal). In addition to the undeca-, hexa-, and pentapeptides 
matured from SMR1 precursor by selective cleavage at pairs of 
basic amino acid residues, an heptapeptide named SGP-T and, 
probably generated from the C-terminus of SMR1. has been 
identified from rat SMG (32). 
Taken together, all these findings provide convincing evidence 
that the androgen-dependent SMR1 protein, mainly produced 
by the rat SMG, is a novel prohormone. It is a precursor of mature 
peptides in a way similar to the preproopiomelanocortin hormone 
precursor which is mainly produced by the pituitary gland and 
generates distinct peptides involved in variety of local and 
peripheral biological events (33). 
REGULATION OF SH/IR1 (VCSA1) GEME EXPRESSION 
• Differential accumulation of mRNASMR1 
TheSMRl transcripts are about 1000 fold more abundant in the 
SMG of male than female rats. Androgens were shown to be 
involved in this regulation, and castration results in the decrease 
of mRNA
SMRI
 accumulation in the rat SMG, while injection of 
androgens to castrated males or to females induces mRNA
SMR1 
accumulation at a level similarto that of intact males (10). Whether 
the effect of androgens on VCSA1 expression is direct or not, is 
at pesent not known. However, nuclear run on experiments 
demonstrate that at least part of this regulation occurs at a 
transcriptional level (Rosinski-Chupin , unpublished data) and 
potential androgen-responsive elements are present in the 
VCSA1 sequence (11). While the other previously studied 
androgen-regulated genes of the SMG are expressed in the cells 
of the granular convoluted tubules, the SMR1 transcripts were 
only detected by in situ hybridization in the acinar cells of rat 
SMG (25). As expected, SMR1 transcripts are present in high 
concentrations in all the acinar cells of male glands. In the fema 
les only some cells appear positive. ' 
• Differential biosynthesis of SMR1 mature peptides 
The quantitative profile of tissue expression and secretion of 
peptides maturated from SMR1 precursor was earned out using a 
radioimmunoassay (RIA) specific for the C-terminus of the 
three peptides, including the undeca-, hexa-, and pentapeptides, 
and a combination of high performance liquid chromato-graphy 
(HPLC) analysis. 
The biosynthesis of the peptides generated from SMR 1 by 
cleavage at pairs of arginine residues is subject to distinct 
regulatory pathways depending on (Tjthe organ, with selective 
accumulation in SMG and prostate, (ii) the sex, with 
predominant accumulation in the male gland, and (in) the age of 
the rat with delectability from 6 week-old SMG. The highest 
accumulation ofSMRl mature peptides is in the SMG of adult male 
rat from ten weeks onwards (maximum value represents about 10 
mg peptides per gland) (31). In accordance with the 
demonstration of androgen-induced expression of mRNA
SMRI
, the 
SMG accumulation of SMR1 mature peptides appears to be also 
dependent on the integrity of the hypothalamic-pituitary-gonad 
axis. In-, deed, in 4 week-old hypophysectomized or 
gonadectomized male rats, the accumulation of mature peptides 
measured 2 or 5 weeks later, respectively, is highly reduced, e.g. 
close to one or two orders of magnitude less abundant than in 
the SMG of sham-operated animals (Fig. 3). For various reasons 
inherent to surgical procedures and its physiological 
consequences, the pituitary gland ablation is less effective than 
gonad's, in term of circulating testosterone levels as well as of 
SMG accumulating SMR1 peptide levels. Therefore, a close 
relationships between the levels of glandular SMR1 peptide 
accumulation and that of plasma testosterone concentration was 
able to be established. Otherwise, female SMG is characterized by 
low levels of mature peptides, in all experimental conditions, e.g. 
close to two orders of magnitude less abundant than in male 
SMG and, by wide variability among individuals. 
REGULATION OF SMR1 -HEXAPEPTIDE AND SMR1 -
PENTAPEPTIDE SECRETION 
• Differential exocrine secretion 
The exocrine secretion of polypeptides of rodent SMG origin is 
known to be regulated by the autonomic nervous system, main- * 
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(34,35). The SMR1 mature undeca-, hexa- and pentapeptides 
which accumulate in the adult male rat SMG are released into the 
saliva of anaesthetized animals in basal condition and in 
response to pharmacological stimuli. Release of these peptides 
is drastically increased in the male rat saliva after the 
administration of a-adrenergic agonist, epinephrine, or p-
adrenergic agonist, isoproterenol (maximum value represents 1 -2 
mg peptides over the SOminpostinjection period of saliva 
collection) (31,36) (Fig. 4). This result is in accordance with 
mRNASMRI distribution in the acinar cells of SMG (25). 
Indeed, protein secretions from SMG acini have been described to 
be essentially under adrenergic control (37). 
• Differential endocrine secretion and characteriza 
tion of circulating SMRT maturation peptides 
A combination of HPLC analysis and RIA detection, performed 
on methanol-extracted rat plasma, demonstrate that SMR1 
peptides, aside from their exocrine transport, are also carried by 
the circulation of adult male rats (31). Thus, from adrenergic 
receptor agonist-treated male rats, the circulating SMR1 
peptides correspond primarily to the SMR1 -pentapeptide (56 
%), the rest corresponds to the SMRl-hexapeptide (35 %) and 
at lesser extent to the SMR1 -undecapeptide (10 %) (Fig. 5). 
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Figure 3. Levels ofSMRl mature peptides in the adult male and female SMG, following pituitary and gonad gland ablations. 
Results are expressed as ng SMR1 mature peptides/mg total proteins and are the mean - SD of independent experiments. See text 
and references for experimentaldetails. GX, gonadectomy: HX, hypophysectomy. Glandablation experiments and the effects on the 
SMG accumulation of tnRNA™'"*' as well as SMRl-peptides, all suggest that the biosynthesis ofSMRl precursor and derived 
peptides is under sex hormone control, in particular androgens. 
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tified by RIA only if blood sampling and extraction steps are 
carried out in the presence of strong metal chelating agent 
(EDTA, DTP A), which is not required for the plasma SMR1-
hexapeptide detection (43). This observation indicates that the 
acid- and methanol- undissociating pentapeptide complex 
involves a plasma molecular species including a mineral ion 
element. Otherwise, as is generally observed for major 
hormones, the final maturation product of SMR1, SMRl -
QHNPR, circulates bound to plasma molecules most likely to 
facilitate its transport to targets and/or regulate its uptake. 
• Sympathetic control of endocrine secretion 
of SMRl mature peptides. This systemic secretory adrenergic 
response is not observed in rats in which the SMG ducts and 
blood vessels are ligated, demonstrating that these circulating 
peptides originate mainly from the SMG (Fig. 6A). Moreover, 
since blood peptide levels are maximal within 10 to 30 min after 
pharmacological induction, it is likely that secretion occurs 
directly from the salivary compartment into the blood circu 
lation rather than through absorption by the gastrointestinal 
tract (Fig. 6B) (31,36). ' , 
• Differential release in conscious and anesthetized 
rats 
From anaesthetized adult male rats, (3- or ap-adrenoceptor-
mediated exocrine secretion of mature peptides results in their 
simultaneous endocrine secretion, demonstrating the adrenergic 
requirement for the local as well as the systemic secretion 
As established for endocrine hormone secretion, the SMG' 
responsiveness to secretagogue is modified under 
anesthetized conditions. Indeed, under basal, as well as 
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Figure 4. Release of SMRl mature peptides from SMG into the saliva of adult male rats, under basal and aittonomic receptor 
agonist-induced conditions. Results are expressed as pmol SMRl-pentapeptide/mg total excreted protein over the 30 min. post-
injection period of saliva collection, and are the m ean - SD of independent experiments. See text and references for experimental 
details. The cholinergic agonist pilocarpine was injected i.p. at 1 mg/kg, thea-adrenergic agonist norepinephrine at 2.5 mg/ 
kg, the /3-adrenergic agonist isoproterenol at 0.5 mg/kg, and lhea/3-adrenei-gic agonist epinephrine at 2.5 mg/kg. The salivary 
secretion of the SMRl mature peptides from SMG is stimulated both by a-and /3-adrenergic mechanisms, however the /3-
adrenergic response is more intense. 
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tides in adult male rats is 5 to 10 times more elevated in conscious 
rather than analgesic, hypnotic and/or myorelaxant 
anesthetized animals: ].9±0.2ng/mlversjjs 0.4±0.l ng/ml under 
basal conditions and ]2.5-5Ang/m\versus 1.2 ± 0.2 ng/ml under 
adrenergic stimulations, respectively (Fig. 7). 
This is why we also explored in conscious rats the ability of SMG to 
respond to pharmacological and/or to endogenous auto-
nomic receptor activation and thereafter, to establish the 
physiological range of circulating SMR1 peptides in vivo. The 
amounts of SMR1 peptides produced by SMG is sex-
dependent and apparently androgen-related. Strikingly, in 
conscious rats, un- 
der basal conditions, the sexual dimorphism of circulating SMR1 
peptides is not as significant: 1.9 ± 0.2 ng/ml for males vs0.7±0.5 
ng/ml for females, although the male SMG still produces more 
than 100 times greater quantity of the peptides compared to 
female SMG (31). Besides, the pharmacological studies in awake 
adult males confirm the differential sensitivity of the glandular 
response to adrenergic receptor agonists in the SMR1 peptide 
systemic secretion. For instance, both the phenylephrine a-
adrenergic agonist plus the isoproterenol |3-adrenergic agonist 
are required to induce extended SMR1 peptide secretory 
response (Fig. 7). Furthermore the endogenous adrenergic 
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Figure 5. Cationic exchange high performance liquid chromatography of methanol-exti'acted plasma obtained from a-adrenergic 
agonist-treated adult male rats. The representative profile is obtained on HEMA-IEC-BIO-WOO carboxymethyl column, with one 
step, 30 min linear gradient of 1-1000 mM ammonium acetate, pH 4.6, at I ml/min flow rate. Fractions are tested after 
lyophilisationfor their immunoreactive SMRl-pentapeptide by a specific RIA (31). From pharmacological-treated male rats, 5 6 -
21  %, n=6 of the plasma SMR1-peptide levels corresponds to free pentapeptide (eluted at 17-19 min), the rest corresponds to 
hexapeptide (24-25 min) and undecapeptide (29 min). Fraction eluted at 4 min represents the undissociated part of the acid- and 
methanol-soluble circulating pentapeptide complex. 
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Figure 6. The pharmacological-induced (A) and time-course (B) secretory response of SMR1 mature peptides into the 
bloodstream of anaesthetized adult male rats. Results are expressed as pmol SMRl-pentapeptide/ml plasma withdrawn 15 min 
before and 15 to 60 min (B) or 15 min (A) after secretogogue administration, and are the mean-SD of independent experiments. 
See text and references for experimental details. The cholinergic agonist pilocarpine was injected i.p. at 1 mg/kg,thea-
adrenergic agonist norepinephrine at 2.5 mg.'kg, the J3-adrenergic agonist isoproterenol at 0.5 mg/kg, and the afl-adrenergic 
agonist epinephrine at 2.5 mg/kg. The rapid systemic secretion of the SMR1 mature peptides from SMG is at least under the 
positive control exerted by the sympathetic nervous system. Otherwises, the process is abolished from male rats in which the 
SMG ducts and blood vessels were surgically ligated. 
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circulating levels of 7.0 ±4.1 ng/ml (43). 
Integrating HPLC analysis and these studies, one can establish 
the physiological range of circulating SMRl-pentapeptide to l-7 
ng/ml in adult male rats. From these observations, one canpose an 
intriguing question about the physiological control and route by 
which the SMRl peptides enter the circulation from the site of 
synthesis in the SMG acini (25). 
• How is this differential secretion orchestrated? 
One possibility is that SMRl peptide systemic secretion is 
controlled by morphologically and functionally distinct regions 
of the SMG, under separate secretory mechanisms and under 
separate autonomic nerve control. Differences in the 
involvement of a- and (3-adrenergic receptor induction in 
protein secretion by the acinar and granular duct cells in the rat 
SMG are well documented (34,3 5,3 7). 
First step, from the site of synthesis to the ductal lumen: The 
evoked "b-type" response on the SM R1 peptide release into the 
SMG excretory ducts is in accordance with the cellular site of 
synthesis and assumes that the exocrine secretory step from the 
SMRl -expressing acinar cells into the lumen of the duct is under 
the predominant control of (3-adrenoceptors. Second step, from 
the ductal lumen to the bloodstream: injection of radiolabeled 
SMR1 -pentapeptide into the main SMG excretory duct of male 
rats results in its rapid appearance in the bloodstream occurring 
even under basal conditions and being augmented under adr-
energic-induced conditions. Furthermore, using recently 
characterized mouse SMG-derived ductal epithelial cell lines (3 8), 
we investigated the ability of these polarized cells, when grown 
as tight monolayers on permeable filter supports, to transcellular 
transport SMRl-pentapeptide. When 2 ng radiolabeled peptide 
is added to the apical medium, 10% of the initially surface-
exposed peptide is recovered in the basolateral medium after six 
hours. Transcytosis of SMRl pentapeptide is time-dependent 
with a half time close to 120 min, and in the apical-to-basolateral 
direction is equal efficient with EGF(8%for2ngEGF). 
This demonstrates that a fraction of SMRl -pentapeptide is able to 
be transported in the apical-to-basolateral direction across the 
SMG ductal cell and subsequently released into the basolateral 
compartment. However, in contrast to transcytosis of EGF that 
occurs preferentially in the basolateral-to-apical direction, the 
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Figure 7. Basal and afi-adrenomimelic agonist-induced systemic secretory response of SMRl-peptides Jrom anesthetized 01 
conscious adult male rats. Results are expressed as ngSMR I-pentapeptide/ml plasma withdrawn 30 min after pharmacologica 
induction, and are the mean-SD of independent experiments. See text and references for experimental details. The a-adrenergic 
agonist phenylephrine plus the /3-adrenergic agonist isoproterenol were injected i.p at 4 ing/kg and at I mg/kg, respectively 
From conscious as from anesthetized male rats, the systemic secretion of SMRl mature peptides is under the positive contra 
exerted through adrenergic receptor activation, however the secretory responsiveness is affected by hypnotic, analgesic and, 
or mvorelaxant anesthetics. 
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both in the apical-to-basolateral and basolateral-to-apical 
directions. As a control, in the same experiments, no transport is 
detected for phenol red, a noninvasive probe which assess the 
development of epithelial confluence and tight junction formation 
(Laoide et al, manuscript in preparation). 
While the exact route of transcellular traffic across epithelial 
ductal cells is not yet known, all these observations indicate that a 
fraction of the SMR1 mature pentapeptide which is being 
routed into the lumen of the duct, could be transported across 
the ductal cells, where it can access fenestrated capillaries 
underlying the duct and subsequently reach the circulation. 
However, further experiments are required in order to identify 
the mechanisms of: (i) transcytotic pathway across the 
polarized ductal cells, and (ii) hormonal and neural controls 
which in vivo direct the systemic secretion under specific 
physiological behavioral and environmental conditions. 
• SMR1 peptide systemic secretion in response to en 
vironmental stress conditions 
The exposure of rats to saturated ether vapor for two minutes is 
used as a acute stress-response model to study the endogenous 
secretion of factors in an integrated physiological context. For 
example, its effect on endogenous adrenalin and adre-
nocorticotropin secretion, two of the major mediators of the 
stress response, is well known (39,40). . ... . • •  
In adult male rats, the systemic secretion of the SMR1 mature 
peptides is rapidly stimulated in response to exposure of ether 
fumes (2 min), while there is no detectable extended release in 
response to a long exposure to stressful ambient temperatures 
(120 min at 4°C or 37°C). The response to acute stress stimuli in 
conscious male rats results in increase of the same order of 
magnitude in circulating levels of SMR1 peptide as those 
obtained under pharmacological adrenergic-induced conditions: 
7.0*4.1 ng/ml versus 12^*5.4ng/ml compared to basal circula-
ting values, 1.9 ± 0.2 ng/ml. This suggests that the circulating 
SMR1 peptide surge is probably initiated and mediated by an 
endogenous adrenergic secretory response to acute stress. 
Complementary to the above experiments it will be necessary to 
determine whether other types of environmental stress result in 
alterations in circulating SMR1 peptides, e.g. exposure to cold-
water, to harmful photic or acoustic conditions as well as physical 
restraint or isolation. All these stressors are well known to 
activate the neuroendocrine hypothalamic-pituitary-adrenal 
axis (39,41,42). Furthermore, determining the circulating levels 
of SMR1 peptides, under behavioral stressful conditions such as 
fighting among males, might give rise to data of physiological 
significance. Another important aspect of the relationships 
between the CST-SMG axis and the response to different 
physiological situations (32) will be to investigate, the effects of 
he- 
modynamic (haemorrhage), hormonal (insulin-induced hypo-
glycemia), and thermoregulatory changes (inflammatory pyretic 
agent-induced fever) on circulating SMR1 peptide levels. 
PERIPHERAL TARGETS FOR CIRCULATING SMR1-
PENTAPEP-TIDE 
• As is basically observed for major hormones of the 
endocrine system, SMR1-pentapeptide is selectively matured 
from the precursor by cleavage at pairs of basic residues, and 
is differentially accumulated and systemically released under 
multifactorial neuroendocrine control. What is the fate of the 
final secretory maturation product of SMRI (SMR1-QHNPR) 
when it arrives in the bloodstream from the saliva? Knowing its 
pharmacodistribution characteristics in vivo should allow one 
to deduce the sites of action, a crucial step in the determination 
of the role of this specific SMG factor. 
• Blood SMRl-pentapeptide distribution and elimina 
tion 
As supported by the pharmacokinetic analysis, when 
discharged into the blood compartment of male rats, the 
SMG-derived pentapeptide is immediately and widely 
distributed in a volume of 35-40 ml/100 g body weight, which is 
similar to the total extracellular fluid volume and is in 
accordance with the hydrophilic property of the peptide. 
Thereafter, the peptide disappears from the blood compartment 
with a distribution half life of close to six minutes, resulting from 
a rapid distribution to target tissues and/or metabolism and 
excretion. The elimination stages occur through metabolism in 
the circulation medium, predominantly from the pentapeptide 
N-terminus, and through glomerular filtration (43). 
• Targettissuedistribution 
By the use of in vivo labeling methods coupled to quantitative-
radio image analysis of whole rat body sections, peripheral 
targets of the final secretory maturation product of SMR1 have 
been identified. The circulating pentapeptide is taken up 
selectively by the renal outer medulla, bone (in particular the 
peri-osteal surface and inner bone), dental tissue and 
glandular gastric mucosa, as well as pancreatic and 
submandibular lobules. The characteristics of tissue uptake allow 
specific binding sites for SMRl-pentapeptide to be identified in 
vivo. As a matter of fact the binding is rapid (at least 90 sec after 
bloodstream accession) and stable, is tissue-specific and 
saturable (dis-placeable in presence of an excess of peptide). 
Furthermore, the peptide hormone binds to tissue receptor sites 
at adult male rat physiological circulating concentrations. 
Direct evidence shows that pentapeptide binding sites are 
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al cells of proximal tubule segments which play a major role in 
the hormonally regulated hydromineral reabsorption and 
secretion processes. The existence of pentapeptide binding sites 
localized within tubular channel processes of trabecular bone, 
alveolar bone and dentinal layers, which are involved in the 
deposition and resorption of mineral ions, gives additional 
evidence that the SMR 1-pentapeptide might be a novel SMG 
hormonal modulator of mineral balance. Otherwise, pancreatic 
acinar cells as well as salivary glands are still sites of ion handling 
and regulation. The differential pentapeptide uptake by these 
tissues supports the hypothesis of a regulatory role of SMR1 -
derived peptide in the systemic control of mineral transport. 
Besides, when one considers that among the targets for the 
pentapeptide, the gastric chief cells, pancreatic acinar cells and 
submandibular tissues have a functional role in early digestive 
processes, the SMR1 peptide maybe also recognized as a 
potential secretagogue for digestive enzymes (43). 
The SMR 1-derived undecapeptide and hexapeptide also reach 
the bloodstream of adult male rats. Undecapeptide has a phar-
macodistribution pattern similar to that of the pentapeptide, in 
fact, this peptide is efficiently metabolized to the pentapeptide in 
the circulation medium. However, the time course of tissue 
distribution of SMR 1-hexapeptide remains to be determined. 
Overall, from these studies realized under physiological 
circulating concentration of pentapeptide, it is important to stress 
the biological relevance of the peripheral pentapeptide uptake 
in vivo which is consistent with the presence of functional 
cellular receptor sites. 
Based on the available evidence of the circulating SMR1 -
pentapeptide selective, rapid, stable and saturable uptake by 
target tissues due to the presence of specific binding sites, one 
can propose that the androgen-regulated SMR 1-derived 
peptides might principally participate as an endocrine factor in 
maintaining systemic mineral homeostasis between the 
skeletal, the dental and the renal mineral transports (Fig. 8). 
CONCLUSION 
• Evidence of physiological significance demonstrate 
the existence of a CST-SMG neuroendocrine axis involved in 
maintaining the rat interior milieu (44). SMR1 precursor, and its 
derived peptides selectively activated in a fashion analogous to 
that ofpolypeptide hormones of more classical neuroendocrine 
system, is at present the only SMG specific components of the 
CST-SMG axis. The gene encoding SMR 1 protein, is a member 
of the VCS family and it is submitted to transcriptional activation 
by gonodal steroids, in particular androgens. Thus, its expres 
sion products which are localized in acinar cells of rat SMG 
display a high level of sexual dimorphism. As for major hor 
mones of the endocrine system, the systemic release of the 
peptides matured from SMR1 precursor, is under the control of 
sympathetic nervous system in particular through a process 
mediated by a(3-adrenergic receptors. The physiological range of 
circulating SMR1 final mature pentapeptide (QHNPR) in 
conscious adult male rats was established to be 1 -7 ng/ml plasma 
depending on the state of activation of adrenoreceptors 
controlling the secretory responsiveness of the SMG. In turn, 
the circulating SMR1 pentapeptide originating from the SMG, is 
selectively taken up by peripheral targets through specific 
binding sites. Hence, localization of primary targets for SMR 1 
pentapeptide suggests a physiological involvement of the 
circulating androgen-dependent peptide in modulating 
systemic mineral ion balance in vivo. 
The androgen-regulated hormone, the SMR1 pentapeptide is 
released into the bloodstream in basal condition and in response to 
adrenomimetic agonist administration orto acute stress stimulus. 
The physiological means and control mechanisms by which 
the peptide leaves the acinar cells and finds its way to the 
circulation in vivo has not been yet identified. However, 
integrating in vitro and in vivo studies, one possible way that this 
may occur is via differential distribution mechanisms within 
local and peripheral fluid from the site of synthesis in acini to 
the effluent blood vessels of the SMG, as follows: (i) by a 
regulated synthesis and secretory pathway which occurs 
predominantly through androgen and a-adrenergic receptors 
respectively, the peptide accesses salivary fluid, and (ii) 
thereby following a transcytotic pathway across epithelial 
ductal cells which is presumably effective through (3-adrenergic 
receptors, the peptide can access adjacent capillaries and 
therefore reach the circulation. Finally, circulating SMR1 
pentapeptide is specifically taken up by peripheral tissues 
involved in mineral balance. It is therefore apparent that SMR1 
peptides, the products elaborated by the SMG, could exert 
hormonal actions on distal cellular targets to enable coordination 
between the different components of the organismic response. 
This endocrine loop between the sites ofproduction of SMR1-
related pentapeptide and sites of uptake and potential action 
can constitute a "long-loop" adjustment system adapted to the 
species-specific environmental, behavioral and physiological 
characteristics. For example, associated with male rat-specific 
behavioral characteristics, e.g. fighting, the SMR 1 -derived 
pentapeptide may be a SMG paracrine and endocrine factor 
which under stressful circumstances is acutely secreted to check 
and balance the local and systemic mineral homeostatic 
responses to stress. In relation with female rat-specific 
physiological characteristics this dynamic regulatory loop may 
match mineral intake and accretion against mineral losses, 
during stages that requires particular adjustments such as 
pregnancy and lactation (45). Finally, in one such integrative 
control mechanism, the SMG might take a remarkable place as a 
glandular system, participating in the stability of internal 
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